Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Clinical Trials (London, England)|January 23, 2025
Experiences with low-intervention clinical trials-the new category under the European Union Clinical Trials RegulationAmos J de Jong, Helga Gardarsdottir, Yared Santa-Ana-Tellez, et al.
Drug Discovery Today|September 16, 2024
Regulatory readiness to facilitate the appropriate use of innovation in clinical trials: The case of decentralized clinical trial approachesAmos J de Jong, Mira G P Zuidgeest, Yared Santa-Ana-Tellez, et al.
BMJ Open|August 29, 2022
Which decentralised trial activities are reported in clinical trial protocols of drug trials initiated in 2019-2020? A cross-sectional study in ClinicalTrials.govAmos J de Jong, Renske J Grupstra, Yared Santa-Ana-Tellez, et al.
British Journal of Clinical Pharmacology|July 13, 2023
Direct-to-participant investigational medicinal product supply in clinical trials in Europe: Exploring the experiences of sponsors, site staff and couriersAmos J de Jong, Yared Santa-Ana-Tellez, Mira G P Zuidgeest, et al.
Drug Discovery Today|February 8, 2023
Decentralised, patient-centric, site-less, virtual, and digital clinical trials? From confusion to consensusYared Santa-Ana-Tellez, Bart Lagerwaard, Amos J de Jong, et al.
Drug Discovery Today|July 23, 2022
Ethics review of decentralized clinical trials (DCTs): Results of a mock ethics reviewTessa I van Rijssel, Amos J de Jong, Yared Santa-Ana-Tellez, et al.
Drug Discovery Today|January 30, 2025
The impact of operational trial approaches on representativeness: Comparison of decentralized clinical trial participants, conventional trial participants, and patients in daily practiceAmos J de Jong, Mira G P Zuidgeest, Yared Santa-Ana-Tellez, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 3, 2023
Opportunities and Challenges for Decentralized Clinical Trial Approaches: European Health Technology Assessment PerspectiveAmos J de Jong, Nadi Shahid, Mira G P Zuidgeest, et al.
Journal of Medical Internet Research|July 9, 2026
Addressing the Key Challenges of Decentralized Clinical Trials in Europe: Multistakeholder Perspective Delphi StudyCarlos Murciano-Gamborino, Lina Pérez-Breva, Amos J de Jong, et al.
BMJ Open|November 9, 2024
Factors affecting the feasibility of post-authorisation RCTs for conditionally authorised anticancer medicines: a multistakeholder perspective from a qualitative focus group studyChristine C van Hattem, Amos J de Jong, Jolien S de Groot, et al.
Pageof 2